<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01825096</url>
  </required_header>
  <id_info>
    <org_study_id>2012p00622</org_study_id>
    <nct_id>NCT01825096</nct_id>
  </id_info>
  <brief_title>Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism</brief_title>
  <official_title>Multi-Modal fMRI/NIRS for Estimation of CMRO2 for Neuroimaging Studies of Drug Abuse and Psychiatric Illness Problems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mclean Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mclean Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal advantages of functional magnetic resonance imaging (fMRI) with&#xD;
      blood-oxygenation- level-dependent (BOLD) contrast for studying brain function are:&#xD;
      non-invasiveness, ubiquitous availability, relatively high spatiotemporal resolution, and the&#xD;
      ability to map function over the entire brain. Thus, BOLD fMRI is the most widely applied&#xD;
      technology to study healthy brain function and pathophysiology associated with disease. In&#xD;
      studies of drug abuse and psychiatric illness though, normal assumptions mapping BOLD signals&#xD;
      to neurometabolism may be violated. Generally, these effects are ignored, resulting in large&#xD;
      study-to-study variability.&#xD;
&#xD;
      Quantitative fMRI (qfMRI) measures metabolism directly and is more suitable for studies of&#xD;
      drug abuse and psychiatric illness. However, qfMRI is too complex for routine use. Cerebral&#xD;
      metabolism during brain activation during visual stimulation measured with a new fMRI&#xD;
      approach that is simple enough for clinical applications will be compared to CMRO2 activation&#xD;
      measured using standard qfMRI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy subjects will undergo a single imaging session. During the imaging session, fMRI and&#xD;
      simultaneous near-infrared spectroscopy measurements will be made during visual stimulation&#xD;
      (e.g., viewing a flashing checkerboard). This is a methods development study focused on&#xD;
      comparing a new method for estimating CMRO2 associated with brain activation with the&#xD;
      standard fMRI approach for estimating CMRO2.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in brain activity associated with visual stimulation</measure>
    <time_frame>cross-sectional, start and up to 6 minutes</time_frame>
    <description>CMRO2 brain activation in visual cortex associated with visual stimulation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>baseline</arm_group_label>
    <description>No intervention. Participants are scanned at baseline.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        1 healthy subject will be recruited for the study from the general population to undergo 12&#xD;
        separate study visits.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  18 to 40 years old&#xD;
&#xD;
          -  Physically healthy by self-report&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Diagnosis of current drug abuse/dependence, including nicotine, as assessed by DSM-IV&#xD;
        criteria&#xD;
&#xD;
          -  Current diagnosis of Axis I disorder using DSM-IV criteria, or any Axis I disorder&#xD;
             within past 5 years&#xD;
&#xD;
          -  Current daily use of antipsychotic, antidepressant, or other psychoactive prescription&#xD;
             drug, as well as daily use of non-prescription drugs&#xD;
&#xD;
          -  Life threatening or unstable medical illness, or one that can create marked change in&#xD;
             mental state&#xD;
&#xD;
          -  Heavy caffeine use (greater than 300 mg on a regular, daily basis)&#xD;
&#xD;
          -  History of seizure disorder&#xD;
&#xD;
          -  Subjects that report any history or current major medical illness (cardiovascular,&#xD;
             pulmonary, psychiatric, or neurological disorders)&#xD;
&#xD;
          -  Subjects who have metal in their body or suffer from claustrophobia cannot participate&#xD;
             in this research study.&#xD;
&#xD;
          -  Additional MR exclusion criteria may include people with:&#xD;
&#xD;
          -  Cardiac pacemakers&#xD;
&#xD;
          -  Metal clips on blood vessels (also called stents)&#xD;
&#xD;
          -  Artificial heart valves&#xD;
&#xD;
          -  Artificial arms, hands, legs, etc.&#xD;
&#xD;
          -  Brain stimulator devices&#xD;
&#xD;
          -  Implanted drug pumps&#xD;
&#xD;
          -  Ear implants&#xD;
&#xD;
          -  Eye implants or known metal fragments in eyes&#xD;
&#xD;
          -  Exposure to shrapnel or metal filings (wounded in military combat, sheet metal&#xD;
             workers, welders, and others)&#xD;
&#xD;
          -  Other metallic surgical hardware in vital areas&#xD;
&#xD;
          -  Certain tattoos with metallic ink (subjects are asked to inform research staff if they&#xD;
             have a tattoo)&#xD;
&#xD;
          -  Metal Containing Intrauterine Devices (IUDs).&#xD;
&#xD;
          -  Certain transdermal (skin) patches such as Transderm Scop (scopolamine for motion&#xD;
             sickness).&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa D Nickerson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mclean Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McLean Imaging Center</name>
      <address>
        <city>Belmont</city>
        <state>Massachusetts</state>
        <zip>02478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>April 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2013</study_first_posted>
  <last_update_submitted>January 3, 2017</last_update_submitted>
  <last_update_submitted_qc>January 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mclean Hospital</investigator_affiliation>
    <investigator_full_name>Lisa Nickerson, PhD</investigator_full_name>
    <investigator_title>Assistant Physicist</investigator_title>
  </responsible_party>
  <keyword>cerebral metabolism</keyword>
  <keyword>functional magnetic resonance imaging</keyword>
  <keyword>near infrared spectroscopy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

